Mutational landscape of RNA-binding proteins in human cancers

Yaseswini Neelamraju1, Abel Gonzalez-Perez2, Poornima Bhat-Nakshatri3

  • 1a Department of Bio Health Informatics, School of Informatics and Computing , Indiana University Purdue University , Indianapolis , Indiana , USA.

RNA Biology
|October 13, 2017
PubMed

Insights

This study maps mutations in RNA Binding Proteins (RBPs) across thousands of cancer genomes, identifying key RBPs driving cancer and revealing their role in post-transcriptional regulation and tumor development.

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Post-transcriptional Regulation

Background:

  • RNA Binding Proteins (RBPs) are crucial for post-transcriptional gene regulation.
  • Dysfunctional RBPs are increasingly implicated in cancer genomes, but their specific roles are not fully understood.
  • A comprehensive analysis of RBP mutations in cancer is needed to elucidate their contribution to tumorigenesis.

Purpose of the Study:

  • To delineate the mutational landscape of approximately 1300 RBPs across nearly 6000 cancer genomes.
  • To identify cancer-specific RBP mutation hotspots and driver RBPs.
  • To investigate the functional impact of RBP mutations on cancer pathways and phenotypes.

Main Methods:

  • Analysis of mutational data from ∼6000 cancer genomes focusing on ∼1300 RBPs.
  • Identification of mutationally enriched RBPs (GEMs) and candidate driver RBPs using the OncodriveFM framework.
  • Functional enrichment analysis, network analysis, and gene knockdown experiments in cancer cell lines.

Main Results:

  • Identified 281 RBPs enriched for mutations (GEMs) across 26 cancer types, with frequent frameshift, deletion, and missense mutations.
  • Discovered over 200 candidate driver RBPs with functionally impactful mutations, affecting pathways like apoptosis, splicing, and translation.
  • Network analysis revealed altered protein interaction networks and cancer-specific RNP mutational hotspots; knockdown experiments showed RBPs mediate cancer-specific stem cell features.

Conclusions:

  • Mutations in RBPs are widespread in cancer and significantly impact post-transcriptional regulatory networks.
  • Specific driver RBPs and their mutational patterns offer potential therapeutic targets and insights into cancer heterogeneity.
  • This study provides a foundational understanding of the RBP mutational spectrum in cancer, paving the way for further investigation into their oncogenic roles.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.8K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K